Hormone Therapy Added to Radiotherapy Benefits Some With Recurrent Prostate Cancer



(MedPage Today) — SAN FRANCISCO — For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits when apalutamide (Erleada) was added to salvage radiotherapy after radical prostatectomy, a randomized…



Source link : https://www.medpagetoday.com/meetingcoverage/astro/117701

Author :

Publish date : 2025-09-29 20:20:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version